Publicaciones (49) Publicaciones de ANE MURUETA-GOYENA LARRAÑAGA

2024

  1. Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease

    npj Parkinson's Disease, Vol. 10, Núm. 1

  2. Prognostic factors for falls in Parkinson’s disease: a systematic review

    Acta Neurologica Belgica, Vol. 124, Núm. 2, pp. 395-406

2023

  1. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study

    Biomedicines, Vol. 11, Núm. 2

  2. Clinical phenotype of postural orthostatic tachycardia associated with anti-adrenergic receptor antibodies

    Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios, Vol. 120, Núm. 2, pp. 66-73

  3. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease (Journal of Neurology, (2023), 270, 1, (519-529), 10.1007/s00415-022-11427-x)

    Journal of Neurology

  4. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies

    Neural Computing and Applications, Vol. 35, Núm. 8, pp. 5603-5617

  5. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

    Journal of Translational Medicine, Vol. 21, Núm. 1

  6. Influence of ocular biometric factors on the defocus curve in an enlarged depth-of-focus intraocular lens

    International Ophthalmology, Vol. 43, Núm. 3, pp. 945-955

  7. Multiple system atrophy: Clinical, evolutive and histopathological characteristics of a series of cases

    Neurologia, Vol. 38, Núm. 9, pp. 609-616

  8. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease

    Journal of Neurology, Vol. 270, Núm. 8, pp. 3821-3829

  9. Sexu-desberdintasunak Parkinson gaixotasunean

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 44, pp. 41-62

2022

  1. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?

    Journal of Translational Medicine, Vol. 20, Núm. 1

  2. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  3. Heart-brain synchronization breakdown in Parkinson’s disease

    npj Parkinson's Disease, Vol. 8, Núm. 1

  4. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 12, Núm. 5, pp. 1633-1643

  5. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease

    Nature Reviews Neurology, Vol. 18, Núm. 4, pp. 203-220

  6. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease

    Journal of Neurology

  7. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis

    Parkinsonism and Related Disorders, Vol. 99, pp. 107-115

  8. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

  9. Spatial characterization of the effect of age and sex on macular layer thicknesses and foveal pit morphology

    PLoS ONE, Vol. 17, Núm. 12 December